Trial Profile
A study investigating pharmacokinetics and pharmacodynamics of linezolid in critically ill severe sepsis or septic shock patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Linezolid (Primary)
- Indications Sepsis; Septic shock
- Focus Therapeutic Use
- 02 Sep 2015 New trial record